losartan has been researched along with Hypovolemia in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Hypovolemia: An abnormally low volume of blood circulating through the body. It may result in hypovolemic shock (see SHOCK).
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with losartan completely blocked the sodium appetite, as well as the induction of Fos-ir in these brain regions." | 1.33 | Role of angiotensin in body fluid homeostasis of mice: effect of losartan on water and NaCl intakes. ( Crews, EC; Rowland, NE, 2005) |
" In the second experiment, furosemide injection was preceded by treatment with a higher dose of CAP; this dosage blocks the peripheral and central formation of angiotensin II." | 1.31 | Activation of renal afferent pathways following furosemide treatment. II. Effect Of angiotensin blockade. ( Fitch, GK; Weiss, ML, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crews, EC | 1 |
Rowland, NE | 1 |
Frithiof, R | 1 |
Eriksson, S | 1 |
Bayard, F | 1 |
Svensson, T | 1 |
Rundgren, M | 1 |
Fitch, GK | 1 |
Weiss, ML | 1 |
3 other studies available for losartan and Hypovolemia
Article | Year |
---|---|
Role of angiotensin in body fluid homeostasis of mice: effect of losartan on water and NaCl intakes.
Topics: Angiotensin II; Animals; Appetite; Body Fluids; Brain; Diet, Sodium-Restricted; Drinking; Homeostasi | 2005 |
Intravenous hypertonic NaCl acts via cerebral sodium-sensitive and angiotensinergic mechanisms to improve cardiac function in haemorrhaged conscious sheep.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiovascular Sys | 2007 |
Activation of renal afferent pathways following furosemide treatment. II. Effect Of angiotensin blockade.
Topics: Afferent Pathways; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme I | 2000 |